Accession Number: | 0001209191-22-001640 |
Date: | 2022-01-03 |
Issuer: | REATA PHARMACEUTICALS INC (RETA) |
Original Submission Date: |
ANAND BHASKAR
5320 LEGACY DRIVE
PLANO, TX 75024
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
CLASS A COMMON STOCK | 2022-01-03 | A | 12,500 | a | $0.00 | 16,500 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 27.32 | 2022-01-03 | deemed execution date | A | 25,000 (a) | 2032-01-03 | class a common stock 25,000 | $27.32 | 25,000 | direct |
ID | footnote |
---|---|
f1 | the shares represent restricted stock units, which vest in sixteen equal quarterly installments beginning on april 3, 2022, subject to continued service through each vesting date. |
f2 | the options vest in sixteen equal quarterly installments beginning on april 3, 2022, subject to continued service through each vesting date. |